These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 18853341)

  • 1. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
    Sarkar FH; Li Y; Wang Z; Kong D
    Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.
    Fraser CC
    Int Rev Immunol; 2008; 27(5):320-50. PubMed ID: 18853342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.
    Peterson JM; Guttridge DC
    Int Rev Immunol; 2008; 27(5):375-87. PubMed ID: 18853344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
    Uwe S
    Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation.
    Blander JM
    Methods Mol Biol; 2009; 512():99-117. PubMed ID: 19347275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of NF-kappaB signaling: 785 and counting.
    Gilmore TD; Herscovitch M
    Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the NF-kappaB signaling pathway: implications for human disease.
    Courtois G; Gilmore TD
    Oncogene; 2006 Oct; 25(51):6831-43. PubMed ID: 17072331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-kappaB in development, prevention, and therapy of cancer.
    Van Waes C
    Clin Cancer Res; 2007 Feb; 13(4):1076-82. PubMed ID: 17317814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB and cancer: mechanisms and targets.
    Karin M
    Mol Carcinog; 2006 Jun; 45(6):355-61. PubMed ID: 16673382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
    Hikoso S; Yamaguchi O; Nakano Y; Takeda T; Omiya S; Mizote I; Taneike M; Oka T; Tamai T; Oyabu J; Uno Y; Matsumura Y; Nishida K; Suzuki K; Kogo M; Hori M; Otsu K
    Circ Res; 2009 Jul; 105(1):70-9. PubMed ID: 19478205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis.
    Kucharczak J; Simmons MJ; Fan Y; Gélinas C
    Oncogene; 2003 Dec; 22(56):8961-82. PubMed ID: 14663476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
    Xiao G; Rabson AB; Young W; Qing G; Qu Z
    Cytokine Growth Factor Rev; 2006 Aug; 17(4):281-93. PubMed ID: 16793322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB activation: from bench to bedside.
    Sethi G; Sung B; Aggarwal BB
    Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity.
    Pai S; Thomas R
    J Autoimmun; 2008 Nov; 31(3):245-51. PubMed ID: 18539434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
    Wong ET; Tergaonkar V
    Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
    Egan LJ; Toruner M
    Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NF-kappaB transcriptional activity.
    Vermeulen L; Vanden Berghe W; Haegeman G
    Cancer Treat Res; 2006; 130():89-102. PubMed ID: 16610704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair.
    Ali S; Mann DA
    Cell Biochem Funct; 2004; 22(2):67-79. PubMed ID: 15027095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.